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Correct establishment of the left/right (L/R) body asym-
metry in the mouse embryo requires asymmetric activa-
tion of the evolutionarily conserved Nodal signaling cas-
cade in the left lateral plate mesoderm (L-LPM). Further-
more, the presence of Nodal in the node is essential for
its own expression in the L-LPM. Here, we have charac-
terized the function of cerl-2, a novel Nodal antagonist,
which displays a unique asymmetric expression on the
right side of the mouse node. cerl-2 knockout mice dis-
play multiple laterality defects including randomization
of the L/R axis. These defects can be partially rescued by
removing one nodal allele. Our results demonstrate that
Cerl-2 plays a key role in restricting the Nodal signaling
pathway toward the left side of the mouse embryo by
preventing its activity in the right side.
Supplemental material is available at http://www.genesdev.org.
Received April 22, 2004; revised version accepted August 4,
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Development of the internal organs proceeds across the
left/right (L/R) axis and becomes apparent during organo-
genesis as a result of asymmetric activation of the con-
served Nodal signaling cascade in the left lateral plate
mesoderm (L-LPM) (for review, see Beddington and Rob-
ertson 1999; Capdevila et al. 2000; Hamada et al. 2002).
Nodal signaling is a crucial player in the correct estab-
lishment of the vertebrate L/R body axis (Capdevila et al.
2000; Wright 2001; Hamada et al. 2002). Nodal expres-
sion in the perinodal region of the embryonic day 7.0
(E7.0) mouse embryo has been shown to be required for
its own activation in L-LPM and thus generate the asym-
metric expression of Nodal’s downstream genes (Bren-
nan et al. 2002; Saijoh et al. 2003). Leftward flow in the
mouse node (nodal flow) generated by specialized cilia
(Nonaka et al. 1998) and intracellular calcium signaling
(McGrath et al. 2003) has been recently implicated in the
initial steps of lateralization. However, the exact mecha-
nism behind the asymmetric Nodal activity in the node
remains largely unexplained (for review, see Hamada et
al. 2002).
We have identified a novel Cerberus/Dan family
member, mouse cerberus-like2 (cerl-2), that is asym-
metrically expressed on the right side of the node. cerl-2
encodes a secreted protein with the capability to bind
directly to Nodal and to inhibit its signaling pathway in
Xenopus assays. Inactivation of mouse cerl-2 resulted in
a wide range of laterality defects including randomiza-
tion of Nodal expression domain in the LPM. These find-
ings are consistent with an important role of cerl-2 in
early events of L/R axis specification. In addition, the
observed abnormalities can be partially rescued by the
removal of one Nodal allele. Our results demonstrate
that Nodal antagonism in the node, mediated by Cerl-2,
is essential for proper specification of the mouse L/R
axis.
Results and Discussion
Using a sequence-similarity-based search, we identified
an incomplete EST sequence (GenBank accession no.
AA289243), later also designated Dante (Pearce et al.
1999) and mouse Coco (Bell et al. 2003) as the cDNA
most related to mouse cerberus-like (Belo et al. 1997) in
the mammalian database. After cloning of the full-length
cDNA, we observed that this gene, here designated cer-
berus-like2 (cerl-2), is located on mouse Chromosome 8,
and is genomically organized into two exons, separated
by an intron of 5.92 kb. It encodes a 20-kDa protein with
a predicted signal peptide sequence and a cysteine-rich
domain (CRD) containing nine cysteines characteristic
of the Cerberus/DAN family (Supplementary Fig. S1).
The CRD domain is essential for the biological function
of these proteins (Belo et al. 1997; Hsu et al. 1998), so it
is important to note that only in Cerl-2 is this complete
domain present, in contrast to what has been previously
described for the incomplete sequence of Dante (Pearce
et al. 1999).
Cerl-2 has close similarities to mouse cerberus-like
(I = 35%, P = 47%), cCaronte (I = 34%, P = 51%), Xcoco
(I = 38%, P = 53%), and to a hypothetical human protein
(I = 57%, P = 65%; Supplementary Fig. S1). The latter is
probably the human homolog of mouse Cerl-2, and we
named it human Cer2. It also shares some similarities
with the recently described zebrafish Charon (I = 33%,
P = 55%).
As shown by whole-mount in situ hybridization
(WISH), cerl-2 transcripts can be first detected in a horse-
shoe-shaped expression pattern in the perinodal region of
the early head-fold stage of the mouse embryo (E7.0; Fig.
1A,A), resembling Nodal expression at this stage (Col-
lignon et al. 1996; Lowe et al. 1996). However, by late
head-fold stage (E7.5), expression of cerl-2 begins to de-
crease in intensity on the left side (Fig. 1B,B), and by
early somitogenesis (E8.0), it can be strongly detected in
the right side of the node (Fig. 1C,C), assuming a
complementary expression pattern to that of Nodal (Col-
lignon et al. 1996; Lowe et al. 1996). After a thorough in
situ hybridization analysis, cerl-2 transcripts could not
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be found in later stages of mouse development. Thus,
cerl-2 is expressed at the proper time and place to be
involved in an early L/R symmetry-breaking event in the
mouse gastrula.
Cerl-2 belongs to a family of secreted antagonists that
are inhibitors of TGF- proteins like Nodal and BMPs,
and also of Wnts, whose specificity can be unveiled by
heterologous assays in the frog embryo (Piccolo et al.
1999; Belo et al. 2000). To assay Cerl-2 activity against
endogenous signals, we injected cerl-2 mRNA (750 pg) in
the marginal zone of Xenopus embryos at the four-cell
stage and then performed WISH for a mesodermal
marker (Xbra) at stage 11. We found that embryos in-
jected with cerl-2 mRNA fail to gastrulate properly and
form mesoderm (data not shown), indicating a possible
interference with endogenous nodal signals. To test this
hypothesis, cerl-2 and mNodal mRNAs were coinjected
in the animal pole of four-cell-stage embryos, animal
caps were explanted at blastula stage, harvested at stage
10.5, and analyzed by RT–PCR for Xbra and Sox17 (a
pan-endodermal marker), two prototypic nodal target
genes (Belo et al. 2000). To test whether inhibition of
mNodal took place upstream or downstream of the
Nodal receptor, we performed epistatic experiments
with a constitutively active form of the activin receptor
(caAlk5). Microinjection of animal caps with either
mNodal (50 pg) or caAlk5 (800 pg) (Fig. 1D, lanes 5,8)
induced expression of both Xbra and Sox17. Coinjec-
tion of mNodal with cerl-2 mRNA (1 ng) completely
blocked mNodal signal (Fig. 1D, lane 6). However, these
inductions could not be prevented when cerl-2 was coin-
jected along with caAlk5, showing that it acts upstream
of this Nodal receptor (Fig. 1D, lane 9). A similar experi-
ment was performed to test if cerl-2 could also inhibit
BMP4 signaling (Fig. 1F). For this experiment, animal
caps were harvested at stage 11, and the downstream
targets Szl1 and Xvent1 were analyzed by RT–PCR. Mi-
croinjection of XBMP4 (300 pg) or caBr (a constitutively
active BMP4 receptor used for the epistatic experiment)
alone induced the expression of both Szl1 and Xvent1
(Fig. 1F, lanes 5,8). Coinjection of cerl-2 (1 ng) with caBr
(480 pg) did not prevent Szl1 and Xvent1 expression (Fig.
1F, lane 9), whereas coinjection of Cerl-2 with XBMP4
inhibited the expression of both markers (Fig. 1F, lane 6).
In both experiments Xcer (800 pg) was injected as a con-
trol as it is known to inhibit both Nodal and BMP4 sig-
naling. Taken together, these results show that full-
length cerl-2 inhibits nodal and BMP4 but not caAlk5 or
caBr signaling (Fig. 1D,F), suggesting that Cerl-2 might
antagonize Nodal and BMP4 extracellularly.
To determine whether Cerl-2 is able to physically in-
teract with TGF proteins, we coinjected synthetic mR-
NAs encoding a Flag-tagged version of Cerl-2 together
with an HA-tagged version of Xnr1 into animal poles.
Extracts were immunoprecipitated with anti-Flag anti-
body and the coprecipitating proteins were analyzed by
anti-HA Western blotting. As shown in Figure 1E,
HAXnr1 protein was found in a complex with FlagCerl2.
All the in vitro experiments—(1) the inhibition of Nodal
and its downstream targets by Cerl-2; (2) its activity be-
ing upstream of the Nodal receptor; and (3) the biochemi-
cal assay showing a physical interaction between the
two proteins—suggest that Cerl-2 is a novel Nodal an-
tagonist.
To determine the in vivo role of cerl-2, we inactivated
this gene in ES cells by replacing the second exon (con-
taining the core CRD) with a LacZ reporter cassette (Fig.
2A). WISH in E7.5 cerl-2+/− embryos using a LacZ probe
revealed that its expression is also asymmetrical in the
right side of the node (Fig. 2D,E). The offspring of Cerl-
2+/− intercrosses were born according to the correct Men-
delian ratio. We observed that 35% of the homozygous
mutants (33/94) died within the first 48 h after birth.
From those animals that died perinatally (n = 33), 18%
(6/33) showed left pulmonary isomerism (Fig. 2G), 18%
(6/33) thoracic situs inversus (Fig. 2H), and the remain-
ing 64% (21/33) failed to show any apparent laterality
defect. However, when these apparently unaffected ani-
mals were examined carefully by histological analysis, it
was observed that they displayed cardiovascular malfor-
mations (Fig. 2J,L), these being their probable cause of
death. These defects include incomplete atrial (Fig. 2L)
and ventricular septation (data not shown). Of the 65%
mutant animals that survived (61/94), 40% become nor-
mal adults (37/94), and the remaining 25% (24/94) die
between weaning age and 3 mo old, most of them show-
ing heterotaxia of the abdominal organs (Supplementary
Fig. S2).
Because of its expression pattern and its Nodal inhibi-
tory activity, together with the observed laterality de-
fects, we decided to investigate the effect of the loss of
cerl-2 in the expression of left–right determinant genes.
At early somite stages, Nodal, Lefty1, Lefty2, and Pitx2
are expressed in the left side of the embryo and are part
of an evolutionarily conserved signaling cascade essen-
Figure 1. Biological activity of the asymmetrically expressed cerl-
2. (A–C) cerl-2 expression pattern during early mouse development.
(A,A) Lateral and anterior views, respectively, of cerl-2 expression
in the node at E7.0. At E7.5 (B), cerl-2 starts to be asymmetrically
up-regulated on the right side of the node, and at E8.0 (C) the asym-
metry becomes more evident. B and C show frontal sections of the
embryos in B and C, respectively, and provide a detailed view of the
perinodal region where cerl-2 is expressed (arrowheads). (D–F) In-
hibitory effects of Cerl-2 on Nodal and BMP signaling. (D) cerl-2
inhibits mNodal but not caALK5 mRNA, as assayed by the induc-
tion of their target genes Xbra and Sox-17. (E) Coimmunoprecipi-
tation experiments showing direct binding of Cerl-2 and Xcer to
Xnr1. (F) cerl-2 inhibits XBMP4 but not caBr mRNA, as assayed by
the induction of their target genes Szl1 and Xvent1.
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tial for correct L/R morphogenesis (Capdevila et al. 2000;
Wright 2001; Hamada et al. 2002). At E8.0, Nodal is ex-
pressed in the node and in the L-LPM of wild-type em-
bryos (Fig. 3A). WISH in cerl-2−/− embryos (N = 60) using
a Nodal probe revealed that although 40% of the em-
bryos showed normal expression, 50% displayed bilat-
eral expression, and 10% had an inverted pattern of ex-
pression in the R-LPM (Fig. 3B–D). Interestingly, Nodal
expression in the node remains unaffected in these three
situations, always being stronger in the left side (red ar-
rows in Fig. 3A–D). This evidence further supports pre-
viously described work in which Nodal asymmetric ex-
pression in the node is reported not to be necessary or
linked to its later expression domain in the L-LPM (Bren-
nan et al. 2002; Saijoh et al. 2003). At this same devel-
opmental stage, Lefty1 is expressed along the ventral
midline in the prospective floor plate of the wild-type
embryo (Fig. 3E), whereas Lefty2 expression can be de-
tected in the L-LPM (Fig. 3E; Meno et al. 1997). Both
genes, Lefty1 and Lefty2, have been described to be
downstream targets of Nodal and also its inhibitors (for
review, see Hamada et al. 2002). By performing WISH
using a riboprobe that detects both Lefty genes, we found
that in cerl-2−/− embryos, Lefty2 expression in the LPM
is very similar to that of Nodal, as it would be expected.
It can be detected in the left LPM, bilaterally or in the
R-LPM (Fig. 3F–H). We could also observe that, in cerl-
2-null mutants, Lefty1 expression in the midline is not
affected (Fig. 3F–H). Lefty1 was proposed to function as a
midline barrier to prevent the diffusion of Nodal-induced
signals emanating from the left to the right LPM (Meno
et al. 1998). The proper expression of Lefty1 (Fig. 3F–H)
and Shh (data not shown) in the prospective floorplate
leads us to conclude that the abnormal expression of left
Figure 3. cerl-2 null mutants display a range of L/R defects. (A–H)
Posterior views of E8.0 embryos. (A) Wild-type Nodal expression in
the node and left LPM. (B–D) cerl-2−/− embryos showing normal (B),
bilateral (C), and right-sided (D) expression of Nodal in the LPM. (E)
Wild-type Lefty2/1 expression in the left LPM and floorplate. (F–H)
cerl-2−/− embryos displaying normal (F), bilateral (G), and right-sided
(H) expression of Lefty2 in the LPM. (I,J) Ventral and dorsal views,
respectively, of E8.5 wild-type embryos showing Pitx2 on the left
LPM. (K–M) cerl-2−/− embryos presenting bilateral (K) and right-sided
(L,M) expression of Pitx2 in the LPM. White arrowheads indicate the
expression domain of Pitx2. (N–P) Rescue of cerl-2 phenotype by
reduced Nodal activity. (N) E9.5 wild-type embryo showing right-
ward looping of the heart. (O) cerl-2−/− littermate with a reversed
heart loop. (P) cerl-2−/−; nodal+/− compound mutant with normal
looping of the heart.
Figure 2. Targeted inactivation of cerl-2 gene. (A) Schematic rep-
resentation of the wild-type cerl-2 locus, targeting vector, and tar-
geted allele. The positions of primers, restriction enzyme sites, and
the probe used for PCR and Southern blot analysis, respectively, are
shown. (B) PCR-based 5-genotyping of wild-type and targeted ES
cell DNA. (C) Genomic Southern blot of PstI-digested tail DNA,
prepared from newborn offspring of a mating of heterozygous mice.
(D,E) LacZ in situ hybridization in wild-type (D) and heterozygous
(E) embryos. (F–H) Thoracic organs of newborn wild-type (F) and
cerl-2−/− littermates displaying left lung isomerism (G) or inverted
situs (H). (I,J) Hearts of newborn wild-type and cerl-2−/− littermates,
respectively. (K,L) Frontal sections of the hearts depicted in I and J,
respectively, showing the atrial septal defects (asterisk) in cerl-2−/−.
(al) Accessory lobe; (cl) caudal lobe; (crl) cranial lobe; (ht) heart; (ml)
middle lobe; (la) left atrium; (llo) left lobe; (lv) left ventricle; (ra) right
atrium; (rlo) right lobe; (rv) right ventricle.
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determinant genes in cerl-2−/− embryos is not caused by
midline defects. Furthermore, 10% of cerl-2−/− embryos
show right-sided ectopic expression of Nodal (Fig. 3D). In
addition, in embryos with bilateral Nodal expression in
the LPM, this expression starts at the level of the node
(Fig. 3C). Taken together, these results strongly indicate
that the leaking of left-side determinants takes place at
the level of the node, and not later through to a defec-
tively patterned midline.
Pitx2 is a downstream target of Nodal that is respon-
sive to Nodal signaling through an asymmetric enhancer
(Shiratori et al. 2001), similar to Lefty2 and Nodal (Ada-
chi et al. 1999; Norris and Robertson 1999; Saijoh et al.
1999). At E8.5, Pitx2 expression can be detected in the
left LPM (Fig. 3I,J; Ryan et al. 1998), and it has been
shown to be required for asymmetric development of
organ situs (Gage et al. 1999; Kitamura et al. 1999; Lin et
al. 1999; Lu et al. 1999). In cerl-2−/− embryos, Pitx2 ex-
pression in the LPM (N = 11) could be detected bilater-
ally (38%), in the left (55%), or in the right side (9%) (Fig.
3K–M).
The L/R-determining genetic cascade leads to morpho-
logical consequences in the positioning of internal or-
gans, and the first morphological manifestation of L/R
axis determination is the orientation of embryonic heart
looping (Fujinaga 1997). In wild-type mouse embryos,
the linear heart tube loops rightward, whereas 54% (27/
50) of cerl-2−/− mice exhibited leftward or ventral heart
looping (Fig. 3K,L). This comes in agreement with the
previous experiments in which we show that Cerl-2 ac-
tivity is essential for the correct establishment of the
left-side determinant genes, and, therefore, it is also nec-
essary for the correct asymmetric development of the
organ situs. In fact, besides the mentioned defects in
heart looping, later developmentally associated pheno-
types like left isomerism, situs inversus, and cardiac
malformation were also observed (Fig. 2F–L).
The phenotype of cerl-2 mutants suggests that Nodal
activity is increased in the node, leading to abnormal
expression of Nodal and its downstream targets in the
LPM. Therefore, we hypothesized that by removing one
copy of the Nodal gene, in the context of the cerl-2 mu-
tant, Nodal activity in the node would be lowered to a
condition more similar to the wild type. To test this, we
intercrossed cerl-2−/− with cerl-2+/−; Nodal+/− animals,
recovered the embryos at E9.5, and scored them accord-
ing to the heart loop direction. Indeed, we could observe
that in cerl-2−/−; nodal+/− embryos (N = 20), the abnormal
heart-looping phenotype was 35% (7/20) (Fig. 3P). Inter-
estingly, from the crosses between cerl-2−/− × cerl-2+/−;
Nodal+/− mutants, we also obtained 17 cerl-2−/− em-
bryos, and of these nine (52%) showed a heart-looping
phenotype, which suggests that although the number of
these embryos is less than half those obtained from cerl-
2−/− crosses, the percentage of defective heart loops re-
mains fairly invariable. This observation (although not
statistically significant owing to the relatively small
number of embryos analyzed) suggests a qualitative ten-
dency to partially rescue this phenotype. This tendency,
as a complement of the other lines of evidence reported
here, is in accordance with the proposed mechanisms for
Cerl-2 activity. Taken together, our results suggest that
the phenotypes in L/R axis determination observed in
cerl-2−/− embryos may result from an excess of Nodal
signaling because of the lack of the Cerl-2 anti-Nodal
activity in the mouse node.
In vitro biochemical assays showed that the Cerl-2
molecule also has the ability of inhibiting BMP-4. The
lack of this potential inhibition in the mutants is, how-
ever, unlikely to be correlated with the in vivo observed
phenotypes. Other studies in which BMP-4 antagonism
was absent from the node, as in the targeted inactivation
of Chordin (Bachiller et al. 2003) and Noggin (McMahon
et al. 1998), did not result in L/R asymmetry-related phe-
notypes.
A gene named Charon that might be an ortholog of
cerl-2 has recently been described in zebrafish. In ze-
brafish, expression of Southpaw and Charon is not asym-
metric. Nevertheless, knockdown of Charon using a
morpholino oligonucleotide produces a similar pheno-
type to that of cerl-2 mutants (Hashimoto et al. 2004).
Although in zebrafish the breaking of L/R symmetry is
still not very well understood, this unveils a possible
conserved evolutionary mechanism of Nodal antago-
nism in the node, mediated by Cerberus/DAN family
members, essential for the correct development of the
L/R axis. In the mouse, Nodal activity in the node is
required for Nodal expression in the L-LPM (Brennan et
al. 2002; Saijoh et al. 2003) and subsequent activation of
Lefty2 and Pitx2. The role we propose for cerl-2 is to
restrict Nodal activity to the left side of the node. The
consequent effect of such inhibition is to prevent addi-
tional activation of Nodal, Lefty2, and Pitx2 in the R-
LPM (Fig. 4). In the absence of Cerl-2 antagonistic activ-
ity on the node, Nodal may be also activated in the R-
LPM, leading to bilateral or ectopic expression of this
genetic cascade in the R-LPM. In addition, we noticed
that Nodal expression on the node is still asymmetric on
the left side of cerl-2 mutants, indicating that cerl-2
doesn’t affect the asymmetric expression of Nodal in the
node. Interestingly, cerl-2 expression in the node
also seems to be independent from Nodal. In fact in
Nodalneo/neo mutants that lack (or have low levels of)
Nodal expression in the node, cerl-2 (Dante) expression
domains remain unchanged (Saijoh et al. 2003).
The maintenance of asymmetric expression of Nodal
in the node of cerl-2 mutants, and later its randomized
expression in the LPM, suggests that it may be un-
coupled from asymmetric gene expression within the
node, as previously described (Brennan et al. 2002; Saijoh
et al. 2003). Although the relevance of Nodal asymmet-
ric expression in the node as the cause of its later expres-
sion domain in the LPM remains unexplained and con-
Figure 4. Proposed model for the role of cerl-2 in generating asym-
metric gene expression. cerl-2 restricts nodal activity to the left side
of the node, preventing additional activation of Nodal, Lefty2, and
Pitx2 in the R-LPM.
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troversial (Saijoh et al. 2003), our data highlight the im-
portance of tight regulation of Nodal activity in the node
by the extracellular antagonism mediated by Cerl-2 as an
integral part of the L/R program.
The first known event for inducing asymmetry in
Nodal expression is the concerted rotational movement
of cilia of the node pit cells (the nodal flow); indeed, in
iv/iv mice that lack such oriented fluid flow, Nodal has
a randomized asymmetric expression in the node (Supp
et al. 1999).
Paradoxically, despite the different expression pattern
of Nodal in the node, of the iv/iv (Supp et al. 1999) and
cerl-2 mutants, they end up displaying a very similar
type of randomization, characterized by left, right, or bi-
lateral activation of the “leftness” program in the LPM.
This indicates that Cerl-2 plays an important role in the
early events of symmetry breaking that take place in the
node. Our data suggest a possible explanation in which
the L/R asymmetry is controlled by a double-assurance
mechanism consisting of two parallel systems, the first
relying on the leftward nodal-cilia flow, and the second,
on the antagonism between Cerl-2 and Nodal described
by the proposed model (Fig. 4).
Materials and methods
Cloning of the full-length CDNA
A cDNA clone (GenBank accession no. AA289245) containing the second
exon and the 3-UTR of cerl-2 was obtained by database search for pro-
teins similar to mCer-l. A hypothetical human protein (FLJ38607) was
found by searching the NCBI database for proteins homologous to cerl-2
and its corresponding cDNA BLASTed against the mouse genome. A
primer designed to align in the predicted 5-UTR (5-CGGAATTCCGC
CAGAAAACAACTCTCAAGCTGCTCTCC-3) and a reverse primer
complementary to the second exon of cerl-2 (5-CCACACCACAGCGT
CACCGATGTCCAGC-3) were used in an RT–PCR with E7.5 mouse
total RNA. The resulting 5-cDNA portion was subcloned into a pGEM-
Teasy vector, and the full-length cDNA was assembled into pCS2+ plas-
mid and sequenced. The GenBank accession number for mouse cerberus-
like2 is AY387409.
Targeted disruption of the cerl-2 gene
A mouse 129/Ola genomic library was screened for cerl-2 using a partial
cDNA clone (GenBank accession no. AA289245), and two positive clones
were obtained.
In our targeting vector, a 0.6-kb SmaI/NcoI DNA fragment containing
the second exon was replaced with a neomycin and a lacz cassette. The
linearized vector was electroporated into 129/Ola embryonic stem cells.
One heterozygous embryonic stem cell clone was used to generate chi-
meric mice by blastocyst injection, and mutant animals were bred in
both 129/Ola and 129/Ola × C57BL/6J mixed backgrounds. Genotyping
was done by Southern blotting and PCR assays. For Southern blot analy-
sis, genomic DNA was digested with PstI and hybridized with a 3-probe.
The 3-probe was a 1.0-kb (PstI/XbaI) genomic DNA fragment down-
stream from the 3 recombination arm. Primers for PCR analysis were P1
(5-GGAACCACCTTTGTAGTCAAGACTGG-3), P2 (5-GGTGACTT
CTTTTTTGCTTTAGCAGG-3), and P3 (5-CACACAGCTGTTGCAG
AAGAC-3).
Generation and genotyping of single and compound mutants
cerl-2+/− heterozygous mice were intercrossed with nodal+/− heterozy-
gous mice (both of C57/B6 background), originating cerl-2−/− or double
heterozygous animals. The latter were crossed to cerl-2+/− or cerl-2−/−
mice to obtain cerl-2−/−; nodal+/− mutants. DNA preparation for geno-
typing was performed as described previously (Lowe et al. 1996) and
analyzed by PCR using the following three oligonucleotides for cerl-2:
AA289c-P3 (5-CACACAGCTGTTGCAGAAGAC-3), GenCer2-fwd (5-
GGAAGATTTTATGCAAGCAAGAGTGTGG-3), and Lower2 (5-
GGTGACTTCTTTTTTGCTTTAGCAGG-3), which resulted in bands
of 300 bp and 500 bp for the wild-type and mutant alleles, respectively.
nodal genotyping was performed as described previously (Bachiller et al.
2000).
Whole-mount in situ hybridization and histology
Whole-mount in situ hybridization and antisense probe preparation was
carried out as described previously (Belo et al. 1997).
Detailed descriptions of the RNA probes and constructs used are avail-
able from the authors on request.
mRNA synthesis, microinjection and RT–PCR analysis
Capped sense mRNAs were synthesized using Ambion mMessage
mMachine kit. In vitro fertilization, microinjection of Xenopus laevis
embryos, and RT–PCR analysis were performed as described previously
(Bouwmeester et al. 1996; Belo et al. 2000). The primer sets used are
described in http://www.hhmi.ucla.edu/derobertis/protocol_page/oligos.
PDF. For all RT–PCR reactions, ef1 was used as the loading control.
Detailed descriptions of the expression constructs used are available
from the authors on request.
Coimmunoprecipitation analysis
A Flag-tagged version of cerl2 was constructed by standard PCR methods
and subcloned in pCS2+, using the abovementioned forward primer and
the following reverse primer: 5-CCGCTCGAGTCACTTATCGTCGT
CATCCTTGTAATCTCCTCCTCCCAGCTTCGGGCGGCACTGACA
CTTCTGG-3. One nanogram of HAXnr1 mRNA and 5 ng of Flagcerl-2
mRNA were injected into the animal poles of Xenopus embryos, and
coimmunoprecipitation was performed as previously described (Yeo and
Whitman 2001). Anti-Flag mouse monoclonal antibody (Sigma) and anti-
HA rabbit polyclonal antibody (Covance) were used for immunoprecipi-
tation and Western blot analysis. Proteins were visualized using
ECLWestern blotting detection reagents (Amersham Pharmacia Biotech).
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